CP
GPCR icon

CenterBook Partners’s Structure Therapeutics GPCR Stock Holding History

CenterBook Partners’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.94M Buy
148,030
+126,793
+597% +$5.61M 0.39% 56
2026
Q1 		$1.02M Buy
+21,237
New +$1.45M 0.06% 349

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CenterBook Partners's GPCR Position: Q2 2026 in Review

CenterBook Partners increased its Structure Therapeutics (GPCR) stake by 597% in Q2 2026, buying an estimated $5.61M and bringing the position to 148,030 shares worth $7.94M. The position accounts for 0.39% of the portfolio, ranked #56.

CenterBook Partners first reported a position in GPCR in Q1 2026 and has held it in 2 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • CenterBook Partners held 148,030 shares of Structure Therapeutics worth $7.94M as of Q2 2026.
  • CenterBook Partners bought 126,793 Structure Therapeutics shares in Q2 2026, an estimated $5.61M.
  • Structure Therapeutics made up 0.39% of CenterBook Partners's portfolio in Q2 2026, its #56 holding.
  • CenterBook Partners first reported a position in Structure Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.